Learning outcomes
By the end of this lesson you should be able to: take a pre-operative history and examination that identifies cardiovascular and respiratory risk; calculate functional capacity in metabolic equivalents and apply the Revised Cardiac Risk Index and the American Society of Anesthesiologists physical status; plan fasting, medication changes and investigations on the basis of an indication rather than routine; and set up the minimum standard of monitoring, including mandatory capnography, temperature and neuromuscular monitoring.
Prerequisites
Lessons 1–7 of this course, especially Lesson 2 (pharmacology) and Lesson 6 (fluid and metabolic management). Anatomy of the neck for the practical skills (jugular vein cannulation and airway assessment) is assumed.
The big idea
The purpose of the pre-operative visit is not to certify a normal patient for elective surgery; it is to identify the things that will change the anaesthetic plan. Three facts do most of this work: functional capacity (how much walking on the flat, or climbing stairs, the patient can do before becoming breathless); the presence of specific comorbidity that changes anaesthetic management; and the medication list, because some drugs are stopped, some are continued and a few are actively dangerous. Investigations follow from this history — a routine 'pre-operative bloods' panel in a fit 30-year-old is a habit, not a risk assessment, and it changes nothing.
Risk stratification
| Tool | What it measures | How it is used |
|---|---|---|
| Functional capacity in metabolic equivalents (METs) | Less than 4 METs = cannot climb a single flight of stairs or walk up a hill; 4–10 METs = moderate; over 10 METs = excellent | Under 4 METs predicts postoperative complications independently, and if the surgery is high risk and the capacity is poor, further cardiac assessment or a change of plan (needle cuff, a regional technique) is indicated |
| ASA physical status I-VI | I: healthy; II: mild systemic disease; III: severe systemic disease limiting activity; IV: constant threat to life; V: moribund; VI: brain dead (organ donor). An E is added for emergency | A simple, universal shorthand for the anaesthetic risk, and the definition used in outcome data and in consent |
| Revised Cardiac Risk Index | High-risk type of surgery, history of ischaemic heart disease, heart failure, stroke or transient ischaemic attack, insulin-dependent diabetes, and serum creatinine above 2 mg/dL | Each factor adds roughly 1.5–2% to the major cardiac complication rate; three or more factors means the risks and benefits must be discussed frankly and the case reconsidered |
| Metabolic exercise testing (CPET, DASI) | Oxygen uptake at the anaerobic threshold | The most reliable pre-operative tool in the uncertain patient, though not available everywhere; considered in the high-risk high-complexity operation with poor functional capacity |
Watch outThe commonest cause of an avoidable peri-operative death in the high-risk patient is a failure of punctual recognition, not of exotic intervention. A patient with poor functional capacity and who is breathless at rest should have their surgery deferred for a reason, with a documented plan for optimisation, rather than being 'cleared' on the day.
Optimising the comorbidity
| Comorbidity | Pre-operative target | Action |
|---|---|---|
| Hypertension | Systolic under 180 and diastolic under 110 in clinic; lower if the surgery is elective and time permits | Continue most antihypertensives; hold angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers on the morning of surgery in the hypotensive-prone patient (a vasodilatory source of hypotension on induction) |
| Ischaemic heart disease | Stable symptoms, and no recent infarction (elective surgery is deferred at least 6 months if possible; if it must proceed, ensure the cardiology plan is current) | Adequate anti-anginal therapy; a cardiology review for unstable symptoms or a recent stent — the antiplatelet plan is decided with the cardiologist and the surgeon |
| Heart failure | Euvolemic, no orthopnoea, a normal chest radiograph if imaged | Optimise diuresis and continue heart-failure therapy echocardiographic review; a newly decompensated patient is cancelled |
| Asthma and COPD | Peak expiratory flow or forced expiratory volume within 20% of the patient's best; no wheeze at examination; no recent exacerbation or antibiotic course without an interval | Continue inhalers; a short preoperative course of steroids (prednisolone 30 mg or hydrocortisone intravenously at induction) if steroid-dependent; regional anaesthesia where possible; a physiotherapy plan for the high risk |
| Diabetes | Glucose 6–10 mmol/L (chloride-corrected); avoid ketones; a target that the ward can achieve with a modified insulin or oral regimen | Variable-rate intravenous insulin infusion and glucose-potassium-insulin protocol in the theatre period for patients with long-duration insulin use, type 1 diabetes, or emergency surgery; monitor for possible DKA and HHS; hold SGLT2 inhibitors to prevent euglycaemic ketoacidosis |
| Obesity and obstructive sleep apnoea | Document the sleep apnoea status and the baseline saturation; an anaesthetic and extubation plan | Ramped positioning, a supraglottic device to hand, extubation awake and sitting up, and a continuous positive airway pressure device in the post-operative period |
| Anaemia | Haemoglobin above the local target, ideally over 100 g/L for high-risk surgery with oral or intravenous iron | Do not transfuse to 'optimise' — use iron and stop the bleeding source; avoid unnecessary blood transfusion |
| Anticoagulants | No active anticoagulation at the time of surgery where the anticoagulant's effect is not needed for the operation | Continue aspirin for cardiac indications; warfarin is stopped 5 days preoperatively with bridging only for high-thrombotic-risk patients (mechanical mitral valve, recent venous thromboembolism); direct oral anticoagulants are held 24–72 hours depending on the agent and renal function; clopidogrel is stopped 5–7 days |
Fasting and the day of surgery
| Item | Fasting rule | Comment |
|---|---|---|
| Clear fluids | 2 hours | Water, clear squash, black tea or coffee without milk; a patient with slow gastric emptying (diabetes, opiates, obesity) may need longer |
| Breast milk | 4 hours | Standard for the infant |
| Light meal / formula milk / cow's milk | 6 hours | Milk is treated as a solid |
| Fried or fatty food / solids generally | 8 hours | Gastric emptying is calorie- and fat-dependent, hence the longer rule |
| Chewing gum and sweets | 6 hours | Treated as solids |
| Carbohydrate loading | A preoperative clear carbohydrate drink 2–3 hours before surgery, per local protocol | Reduces postoperative insulin resistance and thirst and may reduce length of stay; used in the enhanced recovery programme |
| Smoking | Abstain for at least 8–12 hours if possible; a 6–8 week cessation gives the maximum benefit | Even 12 hours reduces carboxyhaemoglobin and nicotine effects; any short cessation is better than none |
Consent for the anaesthetic must be specific and honest: the technique (general, regional, spinal, sedation), its alternatives, the material risks in that patient — airway or dental damage, awareness, nerve injury, a post-dural puncture headache, anaphylaxis, sore throat, nausea, damage from positioning — the fasting and medication instructions, the possibility of a regional or intensive-care intervention, and a plan for postoperative pain. In the UK the anaesthetist is responsible for the anaesthetic consent, not the surgeon, and the documented plan is available to the receiving team.
NoteThe WHO Surgical Safety Checklist structures the day: Sign in (before induction — identity, site, consent, allergy, airway, blood loss available); Time out (before incision — the team introduces itself, the patient, procedure and site are confirmed, anticipated critical events and antibiotic prophylaxis and imaging are stated); Sign out (before leaving — the instrument, swab and needle counts, specimen labelling, recovery plan, postoperative instructions and concerns). The evidence for the checklist in reducing mortality and complications is one of the strongest in patient safety.
Monitoring
The minimum standard of monitoring for any patient receiving general, regional or monitored-anaesthesia-care sedation is continuous electrocardiography, pulse oximetry, non-invasive blood pressure at prescribed intervals (at least every 5 minutes), and — mandatory for any intubated, sedated or anaesthetised patient — waveform capnography. Add temperature, an oxygen analyser with inspired oxygen monitoring, volatile agent concentration, a ventilator disconnect alarm, and, whenever a neuromuscular blocking drug is used, an objective neuromuscular monitor.
| Monitor | What it gives you | Clinical value and pitfalls |
|---|---|---|
| Electrocardiography | Rate, rhythm and continuous ST-segment monitoring | Leads II and V5 detect ischaemia best; standard lead II alone misses lateral changes; artefact from shivering, diathermy or movement is common |
| Non-invasive blood pressure | Systolic, diastolic and mean pressure | Too-large a cuff over-reads; site (upper-arm versus calf) has to be consistent; low perfusion or a cold limb gives inaccurate readings |
| Pulse oximetry | Oxygen saturation and the pulse rate | Unreliable in nil-oxygen-carrying carbon monoxide poisoning, in severe anaemia, in movement and in a vasoconstricted limb; the response is 30+ seconds slow, so desaturation is late |
| Waveform capnography | End-tidal carbon dioxide and the shape of the capnogram | The only reliable confirmation of airway placement and the earliest indication of malignant hyperthermia (a rising end-tidal carbon dioxide) and of inadequate ventilation; obesity and a V/Q shift raise the gradient |
| Neuromuscular monitor | Train-of-four ratio, post-tetanic count | Mandatory whenever a relaxant is used; a ratio of 0.9 or above is the extubation requirement and clinical judgement is not adequate |
| Temperature | Core temperature at two sites where a central neuraxial or long case | Prevents and detects malignant hyperthermia and identifies the hypothermia that worsens coagulopathy and increases wound infection |
| Invasive arterial or central venous pressure | Beat-to-beat pressure, sampling of gases and glucose, central venous oxygen saturation | Reserved for the high-risk patient: haemodynamic instability, planned inotropes, long case, and cardiac and neurosurgery |
| Depth-of-anaesthesia monitor (bispectral index) | Processed EEG-based sedation level | Has a role in reducing awareness in high-risk patients and in titrating titratable total intravenous anaesthesia, but it does not replace the standard set and is affected by muscle relaxants |
Watch outAwareness (unintended intraoperative consciousness) has a real incidence — roughly 1 in 19,000 general anaesthetics in the United Kingdom (NAP5), but 1 in 6700 for obstetric anaesthesia and 1 in 330 in the resuscitation setting where muscle relaxants are used for intubation. Risk factors are a neuromuscular-blockade technique, a long case, cardiac, obstetric and emergency surgery, female sex, difficult-airway or emergency induction and a history of awareness. Prevent by checking that a patient is not paralysed with a visible sedation depth, by giving a supramaximal induction dose and an anaesthetic before the relaxant, and by using a depth monitor in the high-risk patient.
Worked example: one high-risk patient
A 78-year-old with ischaemic heart disease requires an emergency laparotomy for a perforated diverticulum. Functional capacity is 2 METs (breathless climbing one flight of stairs); the Revised Cardiac Risk Index is 2 (age over 65 with ischaemic heart disease, and emergency surgery). The plan is: senior anaesthesia and surgery involvement, an arterial line and a central line before induction, a rapid-sequence induction with etomidate (or ketamine) and rocuronium 1.2 mg/kg, an arterial blood gas, blood-group save and cross-match, a goal-directed fluid and haemodynamic plan with a noradrenaline infusion if needed, tranexamic acid if significant blood loss is anticipated, and a documented postoperative destination (a high-dependency or intensive-care bed arranged before the surgery starts). What is written down is the plan, and the plan starts with the patient's physiology rather than with the theatre list.
Common mistakes
Watch outOrdering 'routine pre-operative tests' without an indication. Normal results in a fit 25-year-old do not change anything, and abnormal results in an untested patient (a mild anaemia of no consequence, a slightly raised creatinine that is chronic) delay surgery without benefit. Investigations follow from history and examination.
Watch outHolding a beta-blocker or a statin before a major operation. Beta-blockers that are chronic are continued (acute initiation of a beta-blocker increases stroke and mortality), and stopping statins has been associated with an increased postoperative cardiac event rate.
Watch outHolding clopidogrel without a plan, or continuing it in a patient booked for intracranial or spinal surgery. The decision is a joint one with the surgeon and cardiologist and has to be documented.
Watch outForgetting the plan for the recovery period: who observes, who receives the oxygen, the analgesia, the fluids and the drain, what are the emergence-and-extubation criteria, and what the escalation criteria are.
Check your understanding
Which elements of the minimum monitoring set are mandatory for a patient undergoing general anaesthesia with a muscle relaxant, and why?
A 70-year-old with type 2 diabetes is listed for a laparoscopic hernia repair. What fasting instructions and perioperative medication plan would you give?
Why is unintended intraoperative awareness more common during emergency intubation in the resuscitation room, and how is it reduced?
Multiple choice
Which is a component of the Revised Cardiac Risk Index?
What is the correct fasting rule for clear fluids before elective general anaesthesia?
A patient with a full stomach requires rapid-sequence induction. Which combination is appropriate?
Which monitoring element is the earliest reliable indicator of malignant hyperthermia in an anaesthetised patient?
Which medication plan is correct for the morning of surgery in a patient on a beta-blocker, a statin, aspirin and an angiotensin-converting enzyme inhibitor?
Summary and next
Pre-operative evaluation is a risk-reduction conversation: functional capacity in metabolic equivalents, the ASA physical status and the Revised Cardiac Risk Index; an optimisation plan for the comorbidity (blood pressure, heart failure, asthma, diabetes, anaemia); fasting of 2 hours for clear fluids, 4 for breast milk, 6 for a light meal and 8 for fatty food; and a specific medication plan. The minimum monitoring set is electrocardiography, pulse oximetry, non-invasive blood pressure and mandatory waveform capnography, with temperature and an objective neuromuscular monitor whenever a relaxant is given, and the day is structured by the WHO checklist.
Next: anaesthetic technique and muscle relaxants in detail, including malignant hyperthermia — the complication whose first sign is the capnography trace you have just learned to read.